What is the Name of Mounjaro for Weight Loss?

Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro is the commercial name for tirzepatide, a prescription medication initially approved by the FDA for type 2 diabetes management. Healthcare providers increasingly prescribe Mounjaro off-label for weight management because clinical trials show it produces significant reductions in body weight when combined with lifestyle modifications. PlexusDx delivers compounded tirzepatide formulations to patients across all 50 states.

What Is Mounjaro and How Does It Work for Weight Loss?

Mounjaro contains tirzepatide, which belongs to a newer class of medications called dual GLP-1/GIP receptor agonists. Unlike older semaglutide-only treatments, tirzepatide activates both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor simultaneously. This dual action suppresses hunger signals in the brain, slows stomach emptying, and enhances feelings of fullness at lower calorie intake.

The medication works by mimicking natural hormones your body produces after eating. When tirzepatide binds to GLP-1 and GIP receptors in your brain and digestive system, it signals satiety, reduces cravings, and stabilizes blood sugar levels. Clinical data from the SURMOUNT trials demonstrated that adults taking tirzepatide lost 20-22% of their baseline body weight over 68 weeks, compared to 2-3% in the placebo group.

Mounjaro Versus Semaglutide: Key Differences for Weight Loss

Mounjaro and semaglutide both suppress appetite, but they engage different pathways in your body. Semaglutide activates only the GLP-1 receptor, while Mounjaro simultaneously targets both GLP-1 and GIP pathways, creating a more potent metabolic effect. Several head-to-head studies indicate that tirzepatide produces greater weight loss than semaglutide alone, with some patients experiencing 2-3 times more weight reduction.

The choice between these medications depends on individual factors like metabolic predisposition, prior treatment response, and personal health history. PlexusDx offers both compounded semaglutide injections (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and compounded tirzepatide injections (at $289/mo month-to-month, or from $249/mo on the 6-month plan), allowing patients to select the option that best matches their clinical profile. The Precision Peptide Genetic Test can identify which GLP-1 and GIP receptor variants you carry, informing whether dual-pathway activation may produce superior outcomes in your case.

Compounded Tirzepatide Versus Brand-Name Mounjaro

Brand-name Mounjaro carries significant out-of-pocket costs and insurance coverage restrictions that limit access for many patients. PlexusDx compounded tirzepatide injections contain the same active pharmaceutical ingredient formulated by licensed 503A compounding pharmacies, delivering identical therapeutic effects at a fraction of the cost. Compounded formulations are HSA/FSA eligible, require no insurance, and no monthly membership fees.

Regulatory oversight of compounded tirzepatide differs from brand-name products in manufacturing location and approval pathway, but compounding pharmacies maintain rigorous quality standards and sterility protocols. PlexusDx tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan across a three-tier commitment structure, with your dose able to increase as needed while maintaining flat monthly pricing. This transparent pricing model eliminates surprise cost escalations as your prescriber optimizes your therapeutic dose.

How Genetic Testing Personalizes Your Tirzepatide Response

Not every patient responds identically to tirzepatide because genetic variations influence how your body processes appetite-suppressing peptides. PlexusDx Precision Peptide Genetic Test analyzes 14 distinct metabolic pathways and 49 peptides to identify genetic predispositions affecting your GLP-1 and GIP receptor function. Key variants like GLP1R rs6923761 and GIPR rs1800437 influence how effectively tirzepatide binds to its target receptors and modulates your hunger response.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, and GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Mounjaro the same as tirzepatide?

Yes, Mounjaro is the brand name for tirzepatide, approved by the FDA for type 2 diabetes and prescribed off-label for weight management. PlexusDx provides compounded tirzepatide formulations with identical active ingredients at lower cost and without insurance requirements.

How much weight can you lose with Mounjaro tirzepatide?

Clinical trials show adults taking tirzepatide lost 20-22% of baseline body weight over 68 weeks, significantly more than semaglutide alone. Individual results vary based on genetics, lifestyle adherence, and metabolic factors that PlexusDx's genetic testing can help clarify.

What does PlexusDx compounded tirzepatide cost?

PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan with no insurance needed, no membership fee, and HSA/FSA eligibility. Your dose may increase as needed without raising your monthly price, following the principle: your dose goes up, your price won't.

Are there side effects with tirzepatide for weight loss?

Common side effects include nausea, vomiting, diarrhea, and constipation, typically mild and transient during the initial weeks. Serious side effects are rare but can include pancreatitis and gallbladder issues; discuss personal risk factors with your prescriber before starting treatment.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The test identifies genetic variants in GLP1R and GIPR genes that influence how effectively your body responds to tirzepatide's dual-pathway mechanism. This personalized insight helps PlexusDx clinicians determine whether tirzepatide, semaglutide, or combination therapies offer the best metabolic outcome for your unique genetic profile.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.